CA1214165A - Pharmaceutical compositions and method of producing alpha.sub.2 antagonism - Google Patents

Pharmaceutical compositions and method of producing alpha.sub.2 antagonism

Info

Publication number
CA1214165A
CA1214165A CA000414027A CA414027A CA1214165A CA 1214165 A CA1214165 A CA 1214165A CA 000414027 A CA000414027 A CA 000414027A CA 414027 A CA414027 A CA 414027A CA 1214165 A CA1214165 A CA 1214165A
Authority
CA
Canada
Prior art keywords
chloro
benzazepine
compound
formula
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000414027A
Other languages
English (en)
French (fr)
Inventor
Robert M. Demarinis
Jacob P. Hieble
William D. Matthews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Inc
Original Assignee
Smith Kline and French Canada Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/398,015 external-priority patent/US4465677A/en
Application filed by Smith Kline and French Canada Ltd filed Critical Smith Kline and French Canada Ltd
Application granted granted Critical
Publication of CA1214165A publication Critical patent/CA1214165A/en
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
CA000414027A 1981-11-27 1982-10-22 Pharmaceutical compositions and method of producing alpha.sub.2 antagonism Expired CA1214165A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32524981A 1981-11-27 1981-11-27
US325,249 1981-11-27
US06/398,015 US4465677A (en) 1982-07-14 1982-07-14 Pharmaceutical compositions and method of producing alpha2 antagonism
US398,015 1982-07-14

Publications (1)

Publication Number Publication Date
CA1214165A true CA1214165A (en) 1986-11-18

Family

ID=26984843

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000414027A Expired CA1214165A (en) 1981-11-27 1982-10-22 Pharmaceutical compositions and method of producing alpha.sub.2 antagonism

Country Status (18)

Country Link
AU (1) AU555672B2 (de)
CA (1) CA1214165A (de)
DD (1) DD205896A5 (de)
DK (1) DK493182A (de)
EG (1) EG16524A (de)
ES (1) ES517697A0 (de)
FI (1) FI823715A7 (de)
GR (1) GR77702B (de)
IE (1) IE53962B1 (de)
IL (1) IL67092A (de)
NO (1) NO158537C (de)
NZ (1) NZ202245A (de)
PH (1) PH18471A (de)
PL (1) PL136452B1 (de)
PT (1) PT75838B (de)
RO (1) RO85262B (de)
YU (1) YU265782A (de)
ZW (1) ZW23382A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4541954A (en) * 1984-09-05 1985-09-17 Smithkline Beckman Corporation Method for preparing 6-chloro-N-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine

Also Published As

Publication number Publication date
ES8405769A1 (es) 1984-06-16
GR77702B (de) 1984-09-25
FI823715A0 (fi) 1982-11-01
FI823715L (fi) 1983-05-28
IL67092A (en) 1987-09-16
YU265782A (en) 1984-12-31
DK493182A (da) 1983-05-28
DD205896A5 (de) 1984-01-11
FI823715A7 (fi) 1983-05-28
ES517697A0 (es) 1984-06-16
IE822486L (en) 1983-05-27
PH18471A (en) 1985-07-18
ZW23382A1 (en) 1983-01-26
RO85262B (ro) 1984-10-30
IL67092A0 (en) 1983-02-23
NZ202245A (en) 1985-09-13
RO85262A (ro) 1984-09-29
EG16524A (en) 1989-06-30
PL136452B1 (en) 1986-02-28
AU9017282A (en) 1983-06-02
IE53962B1 (en) 1989-04-26
PT75838A (en) 1982-12-01
NO158537C (no) 1988-09-28
PL239244A1 (en) 1984-01-02
NO823990L (no) 1983-05-30
NO158537B (no) 1988-06-20
PT75838B (en) 1985-11-12
AU555672B2 (en) 1986-10-02

Similar Documents

Publication Publication Date Title
EP0080779B1 (de) 3-Benzazepine als Alpha-2-antagonisten
HU179917B (en) Process for preparing pyridino- and azepino-triazole derivatives
US4496558A (en) Pharmaceutical compositions and methods for producing alpha antagonism
WO2001072710A1 (en) Heterocycle derivatives and drugs
CA2319649A1 (en) Preventives or remedies for vision disorders
HU190648B (en) Process for preparing n-substituted 2,3,4,5-tetra-hydro-1h-3-benzazepine derivatives
EP1419149B1 (de) Benzo[g]chinolinderivate zur behandlung von glaucom und kurzsichtigkeit
DE60132484T2 (de) Chinazolinderivate und -arzneimittel
JPS6152834B2 (de)
IL102456A (en) Medicinal preparations containing a history of xanthine for the treatment of secondary damage to nerve cells and functional disorders of closed skull-brain injury, some such new compounds
US4465677A (en) Pharmaceutical compositions and method of producing alpha2 antagonism
AU2002328856A1 (en) Benzo (G) quinoline derivatives for treating glaucoma and myopia
CA1214165A (en) Pharmaceutical compositions and method of producing alpha.sub.2 antagonism
EP1480970B1 (de) Chinolinderivate
EP0108170A1 (de) 3-Benzazepine als alpha-2-Antagonisten
US4889856A (en) 7,8-dihydro-4-(1-pierazinyl)-6H-thiopyrano-[3,2-d] pyrimidines as β-blockers
US4994464A (en) Piperazinylpyrimidines as β-adrenergic receptor blockers
US5262422A (en) Octahydrobenzo[g]quinoline
EP2010509B1 (de) 3,4-diamino-3-cyclobuten-1,2-dion-derivate als kaliumkanalöffner
NZ260588A (en) Imidazole derivatives and opthalmic compositions thereof
JPS5951946B2 (ja) イミダゾロン誘導体
NO319401B1 (no) Benzo[g]kinolinderivater, fremgangsmate for fremstilling av samme, farmasoytisk sammensetning omfattende samme og anvendelse av samme for fremstilling av medikament
EP1757601B1 (de) Chinolinderivate und ihre Anwendung bei Glaukom und Kurzsichtigkeit
HK1066211B (en) Benzo [g] quinoline derivatives for treating glaucoma and myopia
HK1071364B (en) Quinoline derivatives

Legal Events

Date Code Title Description
MKEX Expiry